Kabels Asta, Trabjerg Helena Holm, Paulus Felix, Tho Ingunn, Jacobsen Ann-Christin
Drug Transport and Delivery Group, Department of Physics, Chemistry and Pharmacy, University of Southern Denmark, 5230 Odense, Denmark.
Department of Pharmacy, University of Oslo, 0316 Oslo, Norway.
J Control Release. 2025 Oct 10;386:114140. doi: 10.1016/j.jconrel.2025.114140. Epub 2025 Aug 18.
Solidification of lipid-based formulations and dosage form individualization are two trends seen in oral drug delivery. This study proposes an approach for obtaining individualized solid lipid-based formulations, namely, glycerol monostearate-based solid oleogels individualized by molding. Oleogels consist of oil immobilized by a gelling agent. We investigated if it is possible to obtain glycerol monostearate-based oleogels that possess textural properties enabling them to be handled as solid dosage forms. Using DoE, the design space for preparing solid oleogels was established. Here, hardness and stiffness, derived from texture analysis, were used as responses in addition to moldability. The DoE study showed that glycerol monostearate-based solid oleogels can be obtained within a certain design space dependent on the gelling agent concentration, sorbitan monooleate concentration and gel setting temperature. Addition of sorbitan monooleate influenced the textural properties in a non-linear manner. The moldability evaluation yielded limits for hardness and stiffness where molding was possible. To assess the predictability of the DoE models, oleogels with new compositions within the design space were prepared and tested. As a proof-of-concept, ibuprofen-loaded oleogels were prepared and characterized in terms of textural properties, correctness of dosing, and drug release. The textural properties of ibuprofen-loaded oleogels were similar to those without ibuprofen when avoiding low gel setting temperatures. Correct dosing is possible as indicated by tests for uniformity of mass and content uniformity. Before testing ibuprofen release, disintegration was evaluated, indicating very slow disintegration. Disintegration was significantly improved by croscarmellose sodium and sodium starch glycolate. Similarly, during dissolution testing 70 and 25 % ibuprofen was released from glycerol monostearate-based solid oleogels with and without disintegrant, respectively. This study has established a first platform for moldable solid oleogels.
脂质基制剂的固化和剂型个体化是口服药物递送中出现的两种趋势。本研究提出了一种获得个体化固体脂质基制剂的方法,即通过模塑制备基于单硬脂酸甘油酯的固体油凝胶。油凝胶由被胶凝剂固定的油组成。我们研究了是否有可能获得具有使它们能够作为固体剂型处理的质地特性的基于单硬脂酸甘油酯的油凝胶。使用实验设计(DoE),建立了制备固体油凝胶的设计空间。在此,除了可模塑性之外,还将通过质地分析得出的硬度和刚度用作响应指标。DoE研究表明,基于单硬脂酸甘油酯的固体油凝胶可以在取决于胶凝剂浓度、脱水山梨醇单油酸酯浓度和凝胶凝固温度的特定设计空间内获得。添加脱水山梨醇单油酸酯以非线性方式影响质地特性。可模塑性评估得出了能够进行模塑的硬度和刚度极限。为了评估DoE模型的可预测性,制备并测试了设计空间内具有新组成的油凝胶。作为概念验证,制备了载布洛芬的油凝胶,并对其质地特性、剂量正确性和药物释放进行了表征。当避免低凝胶凝固温度时,载布洛芬的油凝胶的质地特性与不含布洛芬的油凝胶相似。质量均匀性和含量均匀性测试表明可以准确给药。在测试布洛芬释放之前,对崩解进行了评估,结果表明崩解非常缓慢。交联羧甲基纤维素钠和淀粉乙醇酸钠可显著改善崩解。同样,在溶出度测试期间,载有和未载有崩解剂的基于单硬脂酸甘油酯的固体油凝胶分别释放了70%和25%的布洛芬。本研究建立了第一个可模塑固体油凝胶平台。